CoChat

Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha‐1‐anti‐trypsin deficiency

Open access

The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Alpha‐1‐anti‐trypsin deficiency is the most common genetic cause of liver disease in children and liver transplantation is currently the only available treatment. Enhancement of liver autophagy increases degradation of mutant, hepatotoxic alpha‐1‐anti‐trypsin (ATZ). We investigated the therapeutic potential of liver‐directed gene transfer of transcription factor EB (TFEB), a master gene that regulates lysosomal function and autophagy, in PiZ transgenic mice, recapitulating the human hepatic disease. Hepatocyte TFEB gene transfer resulted in dramatic reduction of hepatic ATZ, liver apoptosis and fibrosis, which are key features of alpha‐1‐anti‐trypsin deficiency. Correction of the liver phenotype resulted from increased ATZ polymer degradation mediated by enhancement of autophagy flux and reduced ATZ monomer by decreased hepatic NFκB activation and IL‐6 that drives ATZ gene expression. In conclusion, TFEB gene transfer is a novel strategy for treatment of liver disease of alpha‐1‐anti‐trypsin deficiency. This study may pave the way towards applications of TFEB gene transfer for treatment of a wide spectrum of human disorders due to intracellular accumulation of toxic proteins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201202046

Cites

69 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 TFEB induced autophagy dependent ATZ clearance in vitro A–D. Pulse and chase analysis of ATZ in cell lysate (IC) and medium (EC) of wild-type (A) and Atg7−/− (B) MEF transiently co-transfected with either ATZ plus GFP expressing plasmids or ATZ plus TFEB expressing plasmids. The corresponding densitometric analyses from two independent experiments are shown in (C) and (D). The 52 kDa bands correspond to ATZ precursor while mature ATZ is 55 kDa. (A,C) In wild-type MEF, the intracellular, newly synthesized 52 kDa ATZ decreased more rapidly in TFEB transfected cells compared to GFP transfected cells. In media, mature 55 kDa ATZ was secreted in greater amounts in GFP transfected cells compared to TFEB transfected cells. (B,D) Abrogation of autophagy in Atg7−/− MEF abolished TFEB-mediated intracellular clearance of ATZ and secretion of ATZ in media was not affected.E. MEF transiently co-transfected with either ATZ plus GFP expressing plasmids or ATZ plus TFEB expressing plasmids were incubated with proteasome inhibitor MG132 or with DMSO for 6 h. Upon MG132 treatment, steady state levels of 52 kDa ATZ band increased in both cells transfected with ATZ plus GFP and with ATZ plus TFEB expressing plasmids. Quantification of band intensities showed a 48% reduction of ATZ in cells transfected with ATZ plus TFEB compared to cells transfected with ATZ plus GFP, in the absence of the proteasome inhibitor. In MG132 treated cells, a 61% decrease of ATZ was detected in cells transfected with ATZ plus TFEB compared to cells transfected with ATZ plus GFP.F. HeLa cells stably over-expressing TFEB (HeLa-CF7) accumulated less ATZ intracellularly at 24 h post-transfection with a plasmid expressing ATZ. Two independent samples from HeLa and HeLa-CF7 cells are shown. Averages ± standard deviations are shown. *p < 0.05. **p < 0.01. h, hours; NS, not statistically significant.
Figure 1 TFEB induced autophagy dependent ATZ clearance in vitro A–D. Pulse and chase analysis of ATZ in cell lysate (IC) and medium (EC) of wild-type (A) and Atg7−/− (B) MEF transiently co-transfected with either ATZ plus GFP expressing plasmids or ATZ plus TFEB expressing plasmids. The corresponding densitometric analyses from two independent experiments are shown in (C) and (D). The 52 kDa bands correspond to ATZ precursor while mature ATZ is 55 kDa. (A,C) In wild-type MEF, the intracellular, newly synthesized 52 kDa ATZ decreased more rapidly in TFEB transfected cells compared to GFP transfected cells. In media, mature 55 kDa ATZ was secreted in greater amounts in GFP transfected cells compared to TFEB transfected cells. (B,D) Abrogation of autophagy in Atg7−/− MEF abolished TFEB-mediated intracellular clearance of ATZ and secretion of ATZ in media was not affected.E. MEF transiently co-transfected with either ATZ plus GFP expressing plasmids or ATZ plus TFEB expressing plasmids were incubated with proteasome inhibitor MG132 or with DMSO for 6 h. Upon MG132 treatment, steady state levels of 52 kDa ATZ band increased in both cells transfected with ATZ plus GFP and with ATZ plus TFEB expressing plasmids. Quantification of band intensities showed a 48% reduction of ATZ in cells transfected with ATZ plus TFEB compared to cells transfected with ATZ plus GFP, in the absence of the proteasome inhibitor. In MG132 treated cells, a 61% decrease of ATZ was detected in cells transfected with ATZ plus TFEB compared to cells transfected with ATZ plus GFP.F. HeLa cells stably over-expressing TFEB (HeLa-CF7) accumulated less ATZ intracellularly at 24 h post-transfection with a plasmid expressing ATZ. Two independent samples from HeLa and HeLa-CF7 cells are shown. Averages ± standard deviations are shown. *p < 0.05. **p < 0.01. h, hours; NS, not statistically significant.CC BY · PubMed Central
Figure 2 TFEB gene transfer in PiZ mice promoted hepatic ATZ clearance PAS staining was markedly reduced in livers from PiZ mice at 1 month (1 mo) and 6 months (6 mo) after the injection of HDAd-TFEB compared to saline or HDAd-AFP injected mice (magnifications 20× and 40×).ATZ immunofluorescence of livers from HDAd-TFEB injected mice showed a marked reduction of ATZ globules compared to controls at 1 and 6 months post-injection (magnification 20×). Representative images from experimental groups including at least n = 5 mice per group are shown.ELISA for ATZ on hepatic extracts showed a statistically significant reduction of ATZ in HDAd-TFEB injected mice at 1 and 6 months post-injection compared to HDAd-AFP and saline injected controls (at least n = 5 per group).TFEB real time PCR on liver mRNA showed TFEB expression as fold increase over saline at 1 and 6 months post-injection in HDAd-TFEB injected mice (at least n = 5 per group). Averages ± standard deviations are shown. *p < 0.05.
Figure 2 TFEB gene transfer in PiZ mice promoted hepatic ATZ clearance PAS staining was markedly reduced in livers from PiZ mice at 1 month (1 mo) and 6 months (6 mo) after the injection of HDAd-TFEB compared to saline or HDAd-AFP injected mice (magnifications 20× and 40×).ATZ immunofluorescence of livers from HDAd-TFEB injected mice showed a marked reduction of ATZ globules compared to controls at 1 and 6 months post-injection (magnification 20×). Representative images from experimental groups including at least n = 5 mice per group are shown.ELISA for ATZ on hepatic extracts showed a statistically significant reduction of ATZ in HDAd-TFEB injected mice at 1 and 6 months post-injection compared to HDAd-AFP and saline injected controls (at least n = 5 per group).TFEB real time PCR on liver mRNA showed TFEB expression as fold increase over saline at 1 and 6 months post-injection in HDAd-TFEB injected mice (at least n = 5 per group). Averages ± standard deviations are shown. *p < 0.05.CC BY · PubMed Central
Figure 3 Serum ATZ is reduced in HDAd-TFEB injected mice Serum levels of human ATZ were determined by ELISA in PiZ mice injected with HDAd-TFEB and in control animals injected with saline or HDAd-AFP (at least n = 3 per group). Averages ± standard deviations are shown. *p < 0.05; **p < 0.01.
Figure 3 Serum ATZ is reduced in HDAd-TFEB injected mice Serum levels of human ATZ were determined by ELISA in PiZ mice injected with HDAd-TFEB and in control animals injected with saline or HDAd-AFP (at least n = 3 per group). Averages ± standard deviations are shown. *p < 0.05; **p < 0.01.CC BY · PubMed Central
Figure 4 Increased liver autophagy following hepatic TFEB gene transfer in PiZ mice A. Co-staining of liver specimens for LAMP-1 (red) and ATZ (green) showed an increase in LAMP-1 staining at 1 month post-injection in HDAd-TFEB injected PiZ mice. For HDAd-TFEB injected livers the selected field of view shows a region of increased LAMP-1 signal and absent ATZ, surrounding an area of increased ATZ staining (magnification 63×).B,C. Western blots for SQTSTM1/p62 and LC3 showed a decrease in SQTSTM1/p62 and an increase in LC3-I in PiZ mice injected with HDAd-TFEB compared to controls. Representative bands from 3 mice for each treatment group are shown.D,E. The graphs show densitometric quantification of n = 5 mice from each treatment group. Quantification of band intensities was normalized for β-actin.F. Quantification of autophagosome number by EM in wild-type C56BL/6 mice, and saline or HDAd-TFEB injected PiZ mice (n = 32 cells analysed). Averages ± standard deviations are shown. *p < 0.05; **p < 0.01.
Figure 4 Increased liver autophagy following hepatic TFEB gene transfer in PiZ mice A. Co-staining of liver specimens for LAMP-1 (red) and ATZ (green) showed an increase in LAMP-1 staining at 1 month post-injection in HDAd-TFEB injected PiZ mice. For HDAd-TFEB injected livers the selected field of view shows a region of increased LAMP-1 signal and absent ATZ, surrounding an area of increased ATZ staining (magnification 63×).B,C. Western blots for SQTSTM1/p62 and LC3 showed a decrease in SQTSTM1/p62 and an increase in LC3-I in PiZ mice injected with HDAd-TFEB compared to controls. Representative bands from 3 mice for each treatment group are shown.D,E. The graphs show densitometric quantification of n = 5 mice from each treatment group. Quantification of band intensities was normalized for β-actin.F. Quantification of autophagosome number by EM in wild-type C56BL/6 mice, and saline or HDAd-TFEB injected PiZ mice (n = 32 cells analysed). Averages ± standard deviations are shown. *p < 0.05; **p < 0.01.CC BY · PubMed Central
Figure 5 TFEB gene transfer reduced hepatic ATZ monomer and polymer in PiZ mice Representative bands from three PiZ mice for each treatment group are shown. The graph shows densitometric quantification of n = 5 PiZ mice from each treatment group. A statistically significant decrease in both ATZ monomer and polymer was observed in HDAd-TFEB injected mouse livers compared to either saline or HDAd-AFP injected control mice. Averages ± standard deviations are shown. *p < 0.05.
Figure 5 TFEB gene transfer reduced hepatic ATZ monomer and polymer in PiZ mice Representative bands from three PiZ mice for each treatment group are shown. The graph shows densitometric quantification of n = 5 PiZ mice from each treatment group. A statistically significant decrease in both ATZ monomer and polymer was observed in HDAd-TFEB injected mouse livers compared to either saline or HDAd-AFP injected control mice. Averages ± standard deviations are shown. *p < 0.05.CC BY · PubMed Central
Figure 6 Hepatic TFEB gene transfer induced clearance of ATZ inclusions of PiZ mice Livers from either HDAd-AFP injected (A–D) or HDAd-TFEB injected (E–H) PiZ mice were prepared for EM as described in Material and Methods. Scale bar: 1.5 µm (A–C), 340 nm (D), 1.3 µm (E,F), 950 nm (G), 380 nm (H). A–C. Arrows show membrane bound inclusions in the hepatocyte cytoplasm, while asterisks in black indicate nuclei.D. This panel shows the area corresponding to the region outlined by dash box in (C). Arrow indicates the place where inclusion (asterisk in white) is connected with RER membranes.E,F. Hepatocytes in HDAd-TFEB injected animals do not exhibit inclusions in cytoplasm. Asterisks in black indicate nuclei.G. Example of hepatocyte that still contains inclusion (asterisk in white).H. The image shows the area corresponding to the region outlined by dash box in (G). Arrows indicate double membrane around inclusion (asterisk in white).
Figure 6 Hepatic TFEB gene transfer induced clearance of ATZ inclusions of PiZ mice Livers from either HDAd-AFP injected (A–D) or HDAd-TFEB injected (E–H) PiZ mice were prepared for EM as described in Material and Methods. Scale bar: 1.5 µm (A–C), 340 nm (D), 1.3 µm (E,F), 950 nm (G), 380 nm (H). A–C. Arrows show membrane bound inclusions in the hepatocyte cytoplasm, while asterisks in black indicate nuclei.D. This panel shows the area corresponding to the region outlined by dash box in (C). Arrow indicates the place where inclusion (asterisk in white) is connected with RER membranes.E,F. Hepatocytes in HDAd-TFEB injected animals do not exhibit inclusions in cytoplasm. Asterisks in black indicate nuclei.G. Example of hepatocyte that still contains inclusion (asterisk in white).H. The image shows the area corresponding to the region outlined by dash box in (G). Arrows indicate double membrane around inclusion (asterisk in white).CC BY · PubMed Central
Figure 7 Increased ATZ in autophagolysosomes of HDAd-TFEB injected PiZ mice Livers from either HDAd-AFP injected (A,B,D,E) or HDAd-TFEB injected (C,F,G) mice were prepared for immuno-EM of ATZ as described in Materials and Methods Section. Scale bars: 1.8 µm (A), 520 nm (B), 320 nm (C), 125 nm (F), 110 nm (D,E,G). A. Region of the hepatocyte cytoplasm exhibits large membrane bound inclusion (asterisk) similar to that shown in Fig 6B.B. Higher magnification from the region outlined by dash box in A reveals dense gold ATZ labelling over inclusion body (asterisk).C. Arrows indicate diffuse ATZ signal along the RER membranes of hepatocyte in HDAd-TFEB-treated mice.D,E. Lysosomes (arrows) and their intraluminal vesicles (arrowheads) show little or no ATZ in control saline-injected animals.F,G. Liver cells from HDAd-TFEB injected mice exhibit ATZ-corresponding gold particles within the lysosome-like structures (arrows) where ATZ signal is frequently associated with intraluminal vesicles (arrowheads).
Figure 7 Increased ATZ in autophagolysosomes of HDAd-TFEB injected PiZ mice Livers from either HDAd-AFP injected (A,B,D,E) or HDAd-TFEB injected (C,F,G) mice were prepared for immuno-EM of ATZ as described in Materials and Methods Section. Scale bars: 1.8 µm (A), 520 nm (B), 320 nm (C), 125 nm (F), 110 nm (D,E,G). A. Region of the hepatocyte cytoplasm exhibits large membrane bound inclusion (asterisk) similar to that shown in Fig 6B.B. Higher magnification from the region outlined by dash box in A reveals dense gold ATZ labelling over inclusion body (asterisk).C. Arrows indicate diffuse ATZ signal along the RER membranes of hepatocyte in HDAd-TFEB-treated mice.D,E. Lysosomes (arrows) and their intraluminal vesicles (arrowheads) show little or no ATZ in control saline-injected animals.F,G. Liver cells from HDAd-TFEB injected mice exhibit ATZ-corresponding gold particles within the lysosome-like structures (arrows) where ATZ signal is frequently associated with intraluminal vesicles (arrowheads).CC BY · PubMed Central
Figure 8 ATZ content was increased in autophagolysosomes of HDAd-TFEB injected PiZ mice . Immuno-gold ATZ labelling densities (n = 20 cells) in lysosome-like structures were quantified as described in Materials and Methods section and expressed in arbitrary units (AU). Averages ± standard deviations are shown. *p < 0.05.
Figure 8 ATZ content was increased in autophagolysosomes of HDAd-TFEB injected PiZ mice . Immuno-gold ATZ labelling densities (n = 20 cells) in lysosome-like structures were quantified as described in Materials and Methods section and expressed in arbitrary units (AU). Averages ± standard deviations are shown. *p < 0.05.CC BY · PubMed Central
Figure 9 TFEB gene transfer interrupted ATZ pathogenic vicious cycle A. ATZ and endogenous mouse AAT (mAAT) mRNA levels, measured by real time PCR and expressed as fold increase over saline-treated mice were both reduced in HDAd-TFEB injected PiZ mice compared to either saline or HDAd-AFP injected control PiZ mice.B,C. TFEB gene transfer resulted in reduction of calnexin, NFκB, phospho-IκB-α proteins (B) and IL-6 mRNA (C) in the livers of PiZ mice. Real time PCR were performed on mRNA from at least n = 5 mice and are expressed as fold increase over wild-type mice. For Western blots representative bands from three mice for each treatment group are shown. The graph shows densitometric quantification of n = 5 mice from each treatment group. Averages ± standard deviations are shown.D. ATZ accumulation in the ER activates NFκB pathway (Hidvegi et al, 2005) and such activation aggravates the burden of intracellular ATZ. NFκB-dependent increase of IL-6 enhances ATZ expression through binding to the IL-6 responsive element of the AAT promoter (Alam et al, 2012; Morgan et al, 1997). The activating (+) or inhibiting effects (−) induced by TFEB on the molecules involved in this positive feedback mechanism are shown in red. The molecular events occurring in the absence of TFEB gene transfer are shown in black. *p < 0.05; **p < 0.01.
Figure 9 TFEB gene transfer interrupted ATZ pathogenic vicious cycle A. ATZ and endogenous mouse AAT (mAAT) mRNA levels, measured by real time PCR and expressed as fold increase over saline-treated mice were both reduced in HDAd-TFEB injected PiZ mice compared to either saline or HDAd-AFP injected control PiZ mice.B,C. TFEB gene transfer resulted in reduction of calnexin, NFκB, phospho-IκB-α proteins (B) and IL-6 mRNA (C) in the livers of PiZ mice. Real time PCR were performed on mRNA from at least n = 5 mice and are expressed as fold increase over wild-type mice. For Western blots representative bands from three mice for each treatment group are shown. The graph shows densitometric quantification of n = 5 mice from each treatment group. Averages ± standard deviations are shown.D. ATZ accumulation in the ER activates NFκB pathway (Hidvegi et al, 2005) and such activation aggravates the burden of intracellular ATZ. NFκB-dependent increase of IL-6 enhances ATZ expression through binding to the IL-6 responsive element of the AAT promoter (Alam et al, 2012; Morgan et al, 1997). The activating (+) or inhibiting effects (−) induced by TFEB on the molecules involved in this positive feedback mechanism are shown in red. The molecular events occurring in the absence of TFEB gene transfer are shown in black. *p < 0.05; **p < 0.01.CC BY · PubMed Central
Figure 10 Correction of liver disease following TFEB gene transfer A. Sirius red staining in livers from PiZ mice at 1 month (1 mo) and 6 months (6 mo) after the injection of HDAd-TFEB or HDAd-AFP vector. Sirius red staining from a wild-type control is also shown (magnification 20×). Representative images are shown from experimental groups including at least n = 5 mice.B,C. Morphometric analysis of Sirius red staining (B) and hepatic hydroxyproline content (C) showed a reduction of fibrosis in PiZ mice injected with HDAd-TFEB compared to saline or HDAd-AFP injection (at least n = 5 per group) at both 1 month (1 mo) and 6 months (6 mo) post-injection.D. Western blot analysis showed that PiZ mice injected with HDAd-TFEB have a significant reduction of cleaved caspase-12 compared to saline or HDAd-AFP injected mice (representative bands from three independent animals are shown). Band densities of cleaved 42 kDa caspase-12 band normalized for β-actin levels showed a statistical significant reduction in HDAd-TFEB injected mice (n = 5 per group).E. Western blot analysis showed that PiZ mice injected with HDAd-TFEB have a significant reduction of cleaved PARP-1 compared to saline or HDAd-AFP injected mice (representative bands from three independent animals are shown). Densities of cleaved 89 and 24 kDa PARP-1 bands normalized for β-actin levels showed a statistical significant reduction in HDAd-TFEB injected mice (n = 5 per group). Averages ± standard deviations are shown. *p < 0.05, **p < 0.01.
Figure 10 Correction of liver disease following TFEB gene transfer A. Sirius red staining in livers from PiZ mice at 1 month (1 mo) and 6 months (6 mo) after the injection of HDAd-TFEB or HDAd-AFP vector. Sirius red staining from a wild-type control is also shown (magnification 20×). Representative images are shown from experimental groups including at least n = 5 mice.B,C. Morphometric analysis of Sirius red staining (B) and hepatic hydroxyproline content (C) showed a reduction of fibrosis in PiZ mice injected with HDAd-TFEB compared to saline or HDAd-AFP injection (at least n = 5 per group) at both 1 month (1 mo) and 6 months (6 mo) post-injection.D. Western blot analysis showed that PiZ mice injected with HDAd-TFEB have a significant reduction of cleaved caspase-12 compared to saline or HDAd-AFP injected mice (representative bands from three independent animals are shown). Band densities of cleaved 42 kDa caspase-12 band normalized for β-actin levels showed a statistical significant reduction in HDAd-TFEB injected mice (n = 5 per group).E. Western blot analysis showed that PiZ mice injected with HDAd-TFEB have a significant reduction of cleaved PARP-1 compared to saline or HDAd-AFP injected mice (representative bands from three independent animals are shown). Densities of cleaved 89 and 24 kDa PARP-1 bands normalized for β-actin levels showed a statistical significant reduction in HDAd-TFEB injected mice (n = 5 per group). Averages ± standard deviations are shown. *p < 0.05, **p < 0.01.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

Metadata

Authors
Pastore, N., Blomenkamp, K., Annunziata, F., Piccolo, P., Mithbaokar, P., Maria Sepe, R., Vetrini, F., Palmer, D., Ng, P., Polishchuk, E., Iacobacci, S., Polishchuk, R., Teckman, J., Ballabio, A., & Brunetti‐Pierri, N.
Affiliations
  • Telethon Institute Of Genetics And Medicine (IT)
  • Cardinal Glennon Children’s Medical Center (US)
  • Baylor College of Medicine (US)
  • Federico II University Hospital (IT)
Corresponding author
Brunetti‐Pierri, Nicola
Venue
EMBO Molecular Medicine
Published
2013-02-04
Volume
5
Issue
3
Pages
397-412
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W1842277521
Cited by
142
References
71
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 7 · 2021: 13 · 2020: 11 · 2019: 15 · 2018: 8 · 2017: 15 · 2016: 19 · 2015: 11 · 2014: 17 · 2013: 10
FWCI
13.84
Type
journal article
Language
en
Open access
Licence
Locations
  • EMBO Molecular Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Alpha-1 Foundation
  • Ministero della Salute
  • FP7 Ideas: European Research Council (250154)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
TFEB, autophagy, gene transfer, protein clearance, liver fibrosis, liver apoptosis, NF-κB, interleukin-6, lysosomal function
MeSH terms
Autophagy-Related Protein 7, alpha 1-Antitrypsin, Animals, Autophagy, Disease Models, Animal, HeLa Cells, Humans, Liver, Liver Cirrhosis, Lysosomes, Mice, Inbred C57BL, Mice, Transgenic, Microtubule-Associated Proteins, Papio, Phenotype, Time Factors, Transfection, Genetic Therapy, Interleukin-6, NF-kappa B, Apoptosis, Gene Transfer Techniques, Mice, Knockout, alpha 1-Antitrypsin Deficiency, Genetic Predisposition to Disease, Mutation, Missense, Mice, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.